Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian M Adcock

Showing results (1-10 of 513) with videos related to

Pageof 52
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|November 23, 2006
Histone deacetylase inhibitors as novel anti-inflammatory agentsIan M Adcock
Current Allergy and Asthma Reports|March 29, 2003
Glucocorticoids: new mechanisms and future agentsIan M Adcock
Current Opinion in Pharmacology|April 23, 2013
New treatments for COPDAnta Ngkelo, Ian M Adcock
Iranian Journal of Allergy, Asthma, and Immunology|June 17, 2021
MicroRNAs in Human Disease: CommentaryIan M Adcock, Sharon Mumby
Handbook of Experimental Pharmacology|November 20, 2016
GlucocorticoidsIan M Adcock, Sharon Mumby
Biochimie|August 10, 2012
Epigenetics in asthma and COPDMichael Kabesch, Ian M Adcock
Current Drug Targets. Inflammation and Allergy|September 24, 2004
Chemokine receptor inhibitors as a novel option in treatment of asthmaIan M Adcock, Gaetano Caramori
Journal of Inflammation (London, England)|July 12, 2022
Recent evidence from omic analysis for redox signalling and mitochondrial oxidative stress in COPDSharon Mumby, Ian M Adcock
The Journal of Pharmacology and Experimental Therapeutics|February 19, 2025
Protein tyrosine phosphatase 4A3 inhibition: A new pharmacological strategy for acute lung injury?Paolo Montuschi, Ian M Adcock
Current Opinion in Pharmacology|May 14, 2004
Steroid resistance in asthma: a major problem requiring novel solutions or a non-issue?Ian M Adcock, Kazuhiro Ito
Pageof 52

Showing results (1-10 of 513) with videos related to

Sort By:
Pageof 52
Current Opinion in Investigational Drugs (London, England : 2000)|November 23, 2006
Histone deacetylase inhibitors as novel anti-inflammatory agentsIan M Adcock
Current Allergy and Asthma Reports|March 29, 2003
Glucocorticoids: new mechanisms and future agentsIan M Adcock
Current Opinion in Pharmacology|April 23, 2013
New treatments for COPDAnta Ngkelo, Ian M Adcock
Iranian Journal of Allergy, Asthma, and Immunology|June 17, 2021
MicroRNAs in Human Disease: CommentaryIan M Adcock, Sharon Mumby
Handbook of Experimental Pharmacology|November 20, 2016
GlucocorticoidsIan M Adcock, Sharon Mumby
Biochimie|August 10, 2012
Epigenetics in asthma and COPDMichael Kabesch, Ian M Adcock
Current Drug Targets. Inflammation and Allergy|September 24, 2004
Chemokine receptor inhibitors as a novel option in treatment of asthmaIan M Adcock, Gaetano Caramori
Journal of Inflammation (London, England)|July 12, 2022
Recent evidence from omic analysis for redox signalling and mitochondrial oxidative stress in COPDSharon Mumby, Ian M Adcock
The Journal of Pharmacology and Experimental Therapeutics|February 19, 2025
Protein tyrosine phosphatase 4A3 inhibition: A new pharmacological strategy for acute lung injury?Paolo Montuschi, Ian M Adcock
Current Opinion in Pharmacology|May 14, 2004
Steroid resistance in asthma: a major problem requiring novel solutions or a non-issue?Ian M Adcock, Kazuhiro Ito
Pageof 52